Molecular Detection Inc. Company Profile

16:30 EST 14th November 2018 | BioPortfolio

Molecular Detection Inc. (MDI), a US-based company with offices in Wayne, PA, Tunbridge Wells, UK and Jerusalem, Israel, is developing and commercializing a portfolio of "sample-to-answer" Detect-Ready(TM) molecular diagnostic tests for the detection of infectious diseases. The company's first product is a ready-to-use rapid detection hospital-based screening test for MRSA. These staph infections represent a growing problem to the healthcare system. Successful MRSA control efforts rely on screening potential carriers to prevent the spread of the disease. The Detect-Ready(TM) MRSA test provides increased accuracy, faster time to results and more efficient utilization of hospital resources compared to other MRSA diagnostic products. It is currently available in the UK, Germany, Ireland, Switzerland, Austria and Spain, with additional launches expected in the coming months. MDI's real-time PCR tests are based on novel patent-pending technologies for differential diagnosis and room-temperature stabilization. For more information, visit

News Articles [911 Associated News Articles listed on BioPortfolio]

Performance of Blood Culture Molecular Panels Evaluated

High accuracy of direct identification of pathogens from positive blood culture molecular panels is imperative, particularly for the detection of...

Will accelerated Laser PCR benefit time critical molecular tests?

Revolutionising the fundamentals of scientific and medical research. GNA Biosolutions is a Munich-based High-tech engineering firm which has developed instruments, OEM modules, and assays for ultra-fa...

Detection of high-risk carbapenem-resistant Klebsiella pneumoniae and Enterobacter cloacae isolates using volatile molecular profiles

Platform for building healthcare fraud detection applications

I ran across Picalo, an open source fraud detection platform, and thought it might be a great solution for those of us looking to build our own fraud detection systems in healthcare settings. Her...

DIACARTA introduces new QClamp assays for detection of cancer gene mutations

DIACARTA Inc., a precision molecular diagnostics company headquartered in Richmond, California, today announced that it is launching a new suite of CE-IVD marked highly sensitive hydrolysis probe base...

Molecular detection of small hive beetle Aethina tumida Murray (Coleoptera: Nitidulidae): DNA barcoding and development of a real-time PCR assay

USDA Food Safety and Inspection Service Chooses 3M for E. coli, Salmonella and Listeria Testing

3M Food Safety has been awarded a contract from the U.S. Department of Agriculture Food Safety and Inspection Service (USDA FSIS) for pathogen detection instruments and kits. The ...

A molecular sensor for in-situ analysis of complex biological fluids

(The Korea Advanced Institute of Science and Technology (KAIST)) A KAIST research group presented a molecular sensor with a microbead format for the rapid in-situ detection of harmful molecules in bio...

Drugs and Medications [17 Associated Drugs and Medications listed on BioPortfolio]

Thrombin-jmi [King Pharmaceuticals, Inc.]


Pranactin-citric [Otsuka America Pharmaceutical]

Carbon dioxide refrigerated [Linde LLC]

Carbon Dioxide

Carbon dioxide [Linde Merchant Production Inc.]

Carbon Dioxide Refrigerated Liquid USP

Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use Ribavirin safely and effectively. See full prescribing information for Ribavirin.Ribavirin Capsules Initial U.S. Approval: 1998

PubMed Articles [2692 Associated PubMed Articles listed on BioPortfolio]

Comparison of five methods of extraction of Staphylococcus aureus DNA for molecular detection by PCR.

Molecular techniques for the detection of pathogens have been shown to be effective diagnostic tools with high sensitivity and short turnaround times.

In-site synthesis molecular imprinting NbO -based photoelectrochemical sensor for bisphenol A detection.

In this work, a photoelectrochemical (PEC) sensor based on inorganic surface molecular imprinting NbO (MI-NbO) for detection of bisphenol A (BPA) had been developed. In the PEC sensor, MI-NbO material...

Selection of Molecular Markers for the Estimation of Somaclonal Variation.

Tissue culture for plant micropropagation is known to be a source of genetic changes termed "somaclonal variation". This protocol is designed to help in the selection of one or more types of molecular...

Recent technological advancements in tuberculosis diagnostics - A review.

Early diagnosis and on-time effective treatment are indispensable for Tuberculosis (TB) control - a life threatening infectious communicable disease. The conventional techniques for diagnosing TB norm...

Analytical epigenetics: single-molecule optical detection of DNA and histone modifications.

The field of epigenetics describes the relationship between genotype and phenotype, by regulating gene expression without changing the canonical base sequence of DNA. It deals with molecular genomic i...

Clinical Trials [3057 Associated Clinical Trials listed on BioPortfolio]

Assessment of Bmi-1 on Protein and Molecular Levels in Oral Dysplasia and Squamous Cell Carcinoma: A Diagnostic Study

The aim of the current study is to assess the validation of Bmi-1 detection at both protein and molecular levels in oral epithelial dysplasia and oral squamous cell carcinoma as a biomarke...

Detection of Circulating Biomarkers of Immunogenic Cell Death

In this exploratory study, the investigators will investigate if markers (molecular and immunological) of ICD or anti-tumor immunity (exosomal or molecular) can be detected in the serum of...

Molecular Assessment of Drug Resistance Markers in Asymptomatic Malaria Cases and Malaria Antibody Kinetic

Detection of the drug resistance molecular markers for falciparum and vivax in Longitudinal follow-up samples collected in Shwegyin Township, Bago Region that is Artemisinin Resistance Con...

Molecular Diagnosis of Respiratory Viral Infections on Sputum From Cystic Fibrosis Patients

The main objective of this project is to evaluate the agreement between nasopharyngeal and sputum specimens in terms of detection of viral infection in Cystic Fibrosis (CF) participants.Th...

Fluorescence Bronchoscopy and Molecular Characterization of Abnormal Bronchial Lesions: Novel Approaches for Early Detection of Lung Cancer in High Risk Patients

Despite intensive research efforts, there are still no simple and effective screening tools to detect early lung cancer. The majority of newly diagnosed patients have higher stage, often ...

Companies [1332 Associated Companies listed on BioPortfolio]


Xenomics, Inc. is the developer of next-generation molecular diagnostics products that address important health problems worldwide. Our mission is to apply our proprietary transrenal DNA test platfor...

Molecular Detection Inc.

Molecular Detection Inc. (MDI), a US-based company with offices in Wayne, PA, Tunbridge Wells, UK and Jerusalem, Israel, is developing and commercializing a portfolio of "sample-to-answer" Detect-Read...

BioHelix Corporation

BioHelix’s is a molecular diagnostic company focused on improving the quality of healthcare through the development of simple molecular diagnostic tests for the near patient ...

Exact Sciences Corp.

Exact Sciences Corp. is a molecular diagnostics company focused on colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screen...

Prominex, Inc.

Prominex was founded in 2016 with a primary focus on the development of molecular diagnostic assays for point-of-care infectious disease testing. The novel molecular amplification...

More Information about "Molecular Detection Inc." on BioPortfolio

We have published hundreds of Molecular Detection Inc. news stories on BioPortfolio along with dozens of Molecular Detection Inc. Clinical Trials and PubMed Articles about Molecular Detection Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Molecular Detection Inc. Companies in our database. You can also find out about relevant Molecular Detection Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Molecular diagnostics
Molecular diagnostics is a technique used to analyse biological markers in the genome and proteome—the individual's genetic code and how their cells express their genes as proteins—by applying molecular biology to medical testing. The tec...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

MRSA (methicillin-resistant Staphylococcus aureus)
MRSA (methicillin-resistant Staphylococcus aureus) is a family of bacteria with resistance to one or more major antibiotics. There are currently 17 different strains of MRSA. Two particular strains, EMRSA15 and EMRSA16  account for 96% of MRSA blood...

Corporate Database Quicklinks

Searches Linking to this Company Record